journal article·2023-01-13Open access

Heparin-Coated Dendronized Hyperbranched Polymers for Antimalarial Targeted Delivery

María San Anselmo, Elena Lantero, Yunuen Avalos-Padilla, Inés Bouzón-Arnáiz, Miriam Ramírez, Alejandro Postigo, José Luis Serrano, Teresa Sierra, Silvia Hernández-Ainsa, Xavier Fernàndez-Busquets

ACS Applied Polymer Materials· Volume 5· Issue 1

Abstract

High Resolution Image Download MS PowerPoint Slide The rampant evolution of resistance in Plasmodium to all existing antimalarial drugs calls for the development of improved therapeutic compounds and of adequate targeted delivery strategies for them. Loading antimalarials in nanocarriers specifically targeted to the parasite will contribute to the administration of lower overall doses, with reduced side effects for the patient, and of higher local amounts to parasitized cells for an increased lethality toward the pathogen. Here, we report the development of dendronized hyperbranched polymers (DHPs), with capacity for antimalarial loading, that are coated with heparin for their specific targeting to red blood cells parasitized by Plasmodium falciparum . The resulting DHP–heparin complexes exhibit the intrinsic antimalarial activity of heparin, with an IC50 of ca. 400 nM, added to its specific targeting to P. falciparum -infected ( vs noninfected) erythrocytes. DHP–heparin nanocarriers represent a potentially interesting contribution to the limited family of structures described so far for the loading and targeted delivery of current and future antimalarial compounds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Malaria Research and Control · Venomous Animal Envenomation and Studies · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica-Facultad de Ciencias, CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain

Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona 08028, Spain

Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, Barcelona 08036, Spain

Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Martí I Franquès 1, Barcelona 08028, Spain

ARAID Foundation, Government of Aragón, Zaragoza 50018, Spain

Funding

Gobierno de Arag?n · Fundaci?n Ram?n Areces · European Regional Development Fund · Generalitat de Catalunya · European Social Fund · Agencia Estatal de Investigaci?n,Ministerio de Ciencia, Innovaci?n y Universidades

References (45)

Show source-provided references
1. 10.1038/s41467-022-30133-w10.1038/s41467-022-30133-w ↗
2. 10.1002/ppsc.20210015210.1002/ppsc.202100152 ↗
3. 10.1016/j.actatropica.2019.04.02010.1016/j.actatropica.2019.04.020 ↗
4. 10.3390/molecules2419360110.3390/molecules24193601 ↗
5. 10.1016/j.nano.2015.11.01710.1016/j.nano.2015.11.017 ↗
6. 10.2147/ijn.s7631710.2147/ijn.s76317 ↗
7. 10.1016/j.nano.2014.06.00210.1016/j.nano.2014.06.002 ↗
8. 10.1039/c2nr32821f10.1039/c2nr32821f ↗
9. 10.1021/acsami.0c2007010.1021/acsami.0c20070 ↗
10. 10.1038/srep2436810.1038/srep24368 ↗
11. 10.3390/pharmaceutics1209082510.3390/pharmaceutics12090825 ↗
12. 10.1016/j.nano.2016.09.01010.1016/j.nano.2016.09.010 ↗
13. 10.3390/biom1008113610.3390/biom10081136 ↗
14. 10.2217/fmb.14.3010.2217/fmb.14.30 ↗
15. 10.1182/blood-2009-09-24372510.1182/blood-2009-09-243725 ↗
16. 10.1136/bmj.1.5751.71410.1136/bmj.1.5751.714 ↗
17. 10.1016/s0140-6736(72)90621-610.1016/s0140-6736(72)90621-6 ↗
18. Gunawan G. · Paediatr. Indones. · 1991 · 31 · 205
19. Trans. R. Soc. Trop. Med. Hyg. · 1986 · 80 · 310.1016/0035-9203(86)90407-4 ↗
20. 10.1016/j.jconrel.2015.05.28410.1016/j.jconrel.2015.05.284 ↗
21. 10.3390/pharmaceutics1107034110.3390/pharmaceutics11070341 ↗
22. 10.1016/j.jconrel.2016.09.00610.1016/j.jconrel.2016.09.006 ↗
23. 10.1021/acsabm.1c0063510.1021/acsabm.1c00635 ↗
24. 10.1016/j.jconrel.2013.12.03210.1016/j.jconrel.2013.12.032 ↗
25. 10.1039/c8bm01600c10.1039/c8bm01600c ↗
26. 10.1016/j.jconrel.2021.01.02810.1016/j.jconrel.2021.01.028 ↗
27. Fox M. · Acc. Chem. Res. · 2009 · 42 · 114110.1021/ar900035f ↗
28. 10.1016/j.drudis.2019.02.01410.1016/j.drudis.2019.02.014 ↗
29. 10.1016/j.drudis.2019.03.00110.1016/j.drudis.2019.03.001 ↗
30. 10.3390/molecules2309220510.3390/molecules23092205 ↗
31. 10.1016/j.biomaterials.2007.04.00410.1016/j.biomaterials.2007.04.004 ↗
32. 10.1016/j.biomaterials.2014.05.06110.1016/j.biomaterials.2014.05.061 ↗
33. 10.1039/d2bm00365a10.1039/d2bm00365a ↗
34. 10.1002/anie.20110001910.1002/anie.201100019 ↗
35. 10.1016/j.rinphs.2011.12.00210.1016/j.rinphs.2011.12.002 ↗
36. 10.2307/328028710.2307/3280287 ↗
37. 10.1007/978-1-62703-026-7_4010.1007/978-1-62703-026-7_40 ↗
38. 10.1111/j.1462-5822.2004.00394.x10.1111/j.1462-5822.2004.00394.x ↗
39. 10.4155/fmc-2020-002610.4155/fmc-2020-0026 ↗
40. 10.1111/j.1550-7408.1984.tb02968.x10.1111/j.1550-7408.1984.tb02968.x ↗
41. 10.1038/nm.438110.1038/nm.4381 ↗
42. 10.1093/cid/ciw38810.1093/cid/ciw388 ↗
43. 10.1038/s41591-020-1005-210.1038/s41591-020-1005-2 ↗
44. 10.7554/elife.5101510.7554/elife.51015 ↗
45. 10.1186/s12915-022-01374-410.1186/s12915-022-01374-4 ↗